Glaxo Uses Contests To Target Young Hopefuls And Academic Minds
This article was originally published in The Pink Sheet Daily
Executive Summary
With a view to front-loading GlaxoSmithKline’s pipeline, the drug maker’s venture capital arm SR One is increasingly targeting early prospects – to the point of running intense entrepreneurial competitions to fan the flames of innovation in Europe and tap into early startups there.